New research from Fixel and UF Health reveals a promising link between GLP-1 receptor agonists and a reduced risk of Parkinson’s in older adults with type 2 diabetes. The study found a 23% lower risk of PD among GLP-1RA users compared to DPP4i users.
🔗: …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md…pic.twitter.com/ymXGUgCv5v
Teacher, Clinical Supervisor
Clinical Associate Professor, Psychiatry
University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 